Crossmark

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome

Crossref DOI link: https://doi.org/10.1038/s41467-023-37933-8

Published Online: 2023-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Creemers, Jeroen H. A. https://orcid.org/0000-0003-0371-8416
Ankan, Ankur

Roes, Kit C. B.

Schröder, Gijs https://orcid.org/0000-0001-6803-3237
Mehra, Niven https://orcid.org/0000-0002-4794-1831
Figdor, Carl G. https://orcid.org/0000-0002-2366-9212
de Vries, I. Jolanda M. https://orcid.org/0000-0002-8653-4040
Textor, Johannes https://orcid.org/0000-0002-0459-9458
License Information

Text and Data Mining valid from 2023-04-24

Version of Record valid from 2023-04-24
More Information

Article History

Received: 10 September 2021

Accepted: 6 April 2023

First Online: 24 April 2023

Competing interests

: The authors declare no competing interests.